- Home
- GCV vs OKYO Comparison
GCV vs OKYO Comparison
Compare GCV & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GCV | OKYO |
|---|---|---|
| Founded | 1988 | 2007 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.1M | 79.7M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | GCV | OKYO |
|---|---|---|
| Price | $4.21 | $1.72 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 57.9K | ★ 140.8K |
| Earning Date | 01-01-0001 | 07-18-2025 |
| Dividend Yield | ★ 13.04% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.15 | $0.90 |
| 52 Week High | $4.58 | $3.35 |
Technical Indicators
Market Signals| Indicator | GCV | OKYO |
|---|---|---|
| Relative Strength Index (RSI) | 52.49 | 33.32 |
| Support Level | $4.02 | $1.94 |
| Resistance Level | $4.15 | $2.54 |
| Average True Range (ATR) | 0.07 | 0.22 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 79.17 | 0.53 |
Price Performance
Historical ComparisonAbout GCV Gabelli Convertible and Income Securities Fund Inc. (The)
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive and others. All the operation of the group is operated through the regions of United States.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.